SeaStar Medical (ICU) CEO receives 10,288 restricted stock units in equity grant

Rhea-AI Filing Summary

Schlorff Eric reported acquisition or exercise transactions in this Form 4 filing.

SeaStar Medical Holding Corp Chief Executive Officer Eric Schlorff received an equity grant in the form of restricted stock units. The award covers 10,288 shares of common stock at a stated price of $0.00 per share, reflecting a compensation-related grant rather than an open-market purchase.

According to the filing, the restricted stock units will vest in three equal installments on July 1, 2026, November 1, 2026, and March 1, 2027. After this grant, Schlorff holds 50,140 shares of SeaStar Medical common stock directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Schlorff Eric

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.0001	10,288	$0.00	--

Holdings After Transaction: Common Stock, par value $0.0001 — 50,140 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

RSUs granted: 10,288 shares Grant price: $0.00 per share Holdings after grant: 50,140 shares +3 more

6 metrics

RSUs granted 10,288 shares Restricted stock unit award to CEO

Grant price $0.00 per share Stated price for RSU grant

Holdings after grant 50,140 shares Shares directly held after transaction

First vesting date July 1, 2026 First one-third of RSUs vest

Second vesting date November 1, 2026 Second one-third of RSUs vest

Final vesting date March 1, 2027 Final one-third of RSUs vest

Key Terms

restricted stock unit, RSU, vest

3 terms

restricted stock unit financial

"Represents a restricted stock unit award ("RSU")."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

RSU financial

"Represents a restricted stock unit award ("RSU")."

Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.

vest financial

"The RSU will vest in three equal installment on July 1, 2026, November 1, 2026, and March 1, 2027."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 05:11 PM Accepted by SEC EDGAR 07/02/2026 - 05:11 PM Learn about SEC filing dates

FAQ

What insider transaction did SeaStar Medical (ICU) report for CEO Eric Schlorff?

SeaStar Medical reported that CEO Eric Schlorff received a grant of 10,288 restricted stock units. These represent a compensation-related equity award in common stock, not an open-market share purchase, and increase his directly held position in the company.

How many SeaStar Medical (ICU) shares did the CEO hold after this Form 4 transaction?

After the restricted stock unit grant, CEO Eric Schlorff held 50,140 shares of SeaStar Medical common stock directly. This figure reflects his position immediately following the award reported in the Form 4 insider transaction filing.

What are the vesting terms of the SeaStar Medical (ICU) restricted stock units granted to the CEO?

The 10,288 restricted stock units granted to CEO Eric Schlorff vest in three equal installments. Vesting dates are July 1, 2026, November 1, 2026, and March 1, 2027, meaning the award becomes fully vested over this scheduled period.

Was the SeaStar Medical (ICU) CEO’s Form 4 transaction an open-market stock purchase?

No, the transaction was not an open-market purchase. The filing describes a grant of 10,288 restricted stock units at a stated price of $0.00 per share, indicating a compensation-related equity award instead of buying shares on the open market.

What type of security was reported in the SeaStar Medical (ICU) CEO Form 4 filing?

The Form 4 reports an award of restricted stock units tied to SeaStar Medical common stock, par value $0.0001 per share. These units convert into shares as they vest on the specified future vesting dates described in the footnote.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schlorff Eric

(Last) (First) (Middle)

3513 BRIGHTON BLVD

SUITE 410

(Street)

DENVER COLORADO 80216

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SeaStar Medical Holding Corp [ ICU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.0001	07/01/2026		A		10,288(1)	A	$0	50,140	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a restricted stock unit award ("RSU"). The RSU will vest in three equal installment on July 1, 2026, November 1, 2026, and March 1, 2027.

	/s/ Eric Schlorff	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)